Cite
Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.
MLA
Semchenkova, Alexandra, et al. “Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.” International Journal of Molecular Sciences, vol. 23, no. 7, Apr. 2022. EBSCOhost, https://doi.org/10.3390/ijms23074019.
APA
Semchenkova, A., Mikhailova, E., Komkov, A., Gaskova, M., Abasov, R., Matveev, E., Kazanov, M., Mamedov, I., Shmitko, A., Belova, V., Miroshnichenkova, A., Illarionova, O., Olshanskaya, Y., Tsaur, G., Verzhbitskaya, T., Ponomareva, N., Bronin, G., Kondratchik, K., Fechina, L., … Popov, A. (2022). Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy. International Journal of Molecular Sciences, 23(7). https://doi.org/10.3390/ijms23074019
Chicago
Semchenkova, Alexandra, Ekaterina Mikhailova, Alexander Komkov, Marina Gaskova, Ruslan Abasov, Evgenii Matveev, Marat Kazanov, et al. 2022. “Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.” International Journal of Molecular Sciences 23 (7). doi:10.3390/ijms23074019.